Tumorous deformity of mitral valve leaflet after chordal rupture in a child

Koichi Tamura1, Yuichi Sugisaki, Shunichi Ogawa

  • 1Division of Surgical Pathology, Nippon Medical School Hospital, Tokyo, Japan. tamura@nms.ac.jp

Pathology International
|February 1, 2003
PubMed

Insights

A child developed a tumorous mitral valve deformity after chordal rupture. This overgrowth of valve tissue, driven by mitral regurgitation, may involve an imbalance of matrix metalloproteinases and tissue inhibitors.

Area of Science:

  • Cardiovascular Pathology
  • Pediatric Cardiology
  • Surgical Pathology

Background:

  • Spontaneous chordal rupture in the mitral valve can lead to regurgitation and leaflet complications.
  • Tumorous deformities of heart valves are rare, particularly in pediatric cases.

Observation:

  • A 9-year-old boy presented with a posterior mitral leaflet deformity following partial chordal rupture.
  • Echocardiography revealed gradual development of tumorous bulging over 5 years.
  • Histological analysis showed myxomatous material, mesenchymal cells expressing Vimentin, PCNA, MMP-1, MMP-2, and TIMP-1.

Findings:

  • The tumorous mitral valve lesion consisted of myxomatous tissue with disorganized collagen and elastic fibers.
  • Mesenchymal cells within the lesion exhibited high proliferation (PCNA index 29.3%) and expressed MMPs and TIMPs.
  • An imbalance in matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) activity was noted, particularly reduced TIMP-2 reactivity at the lesion surface.

Implications:

  • Mitral regurgitation following chordal rupture can stimulate valve tissue overgrowth, leading to tumorous deformities.
  • The imbalance between MMPs and TIMPs appears crucial in the pathogenesis of this mitral valve bulge formation.
  • Understanding these molecular mechanisms may inform future therapeutic strategies for valvular heart disease in children.

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...